Stock Price
616.80
Daily Change
3.00 0.49%
Monthly
-13.15%
Yearly
10.10%
Q1 Forecast
598.33

argenx SE reported $387.05M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AstraZeneca USD 5.23B 272M Sep/2025
Galapagos EUR 2.42M 161.13M Sep/2025
Genmab DKK 477M 101M Sep/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Qiagen NV USD 249.69M 56.53M Dec/2025
UCB EUR 1.03B 334M Jun/2025